JP2002544227A - 新規ジフェニルエチレン化合物 - Google Patents

新規ジフェニルエチレン化合物

Info

Publication number
JP2002544227A
JP2002544227A JP2000617889A JP2000617889A JP2002544227A JP 2002544227 A JP2002544227 A JP 2002544227A JP 2000617889 A JP2000617889 A JP 2000617889A JP 2000617889 A JP2000617889 A JP 2000617889A JP 2002544227 A JP2002544227 A JP 2002544227A
Authority
JP
Japan
Prior art keywords
compound
hydrogen
ome
composition
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000617889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002544227A5 (enExample
Inventor
ナグ、ビシュワジット
メディチャーラ、サティアナラヤナ
デイ、デベンドラナス
Original Assignee
カリックス セラピューティックス インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カリックス セラピューティックス インコーポレイテッド filed Critical カリックス セラピューティックス インコーポレイテッド
Publication of JP2002544227A publication Critical patent/JP2002544227A/ja
Publication of JP2002544227A5 publication Critical patent/JP2002544227A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/40—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals
    • C07C15/50—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts substituted by unsaturated carbon radicals polycyclic non-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2000617889A 1999-05-18 1999-05-18 新規ジフェニルエチレン化合物 Pending JP2002544227A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/011001 WO2000069430A1 (en) 1999-05-18 1999-05-18 Novel diphenylethylene compounds

Publications (2)

Publication Number Publication Date
JP2002544227A true JP2002544227A (ja) 2002-12-24
JP2002544227A5 JP2002544227A5 (enExample) 2006-07-13

Family

ID=22272785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000617889A Pending JP2002544227A (ja) 1999-05-18 1999-05-18 新規ジフェニルエチレン化合物

Country Status (9)

Country Link
EP (1) EP1178788A4 (enExample)
JP (1) JP2002544227A (enExample)
KR (1) KR100598638B1 (enExample)
CN (1) CN1194674C (enExample)
AU (1) AU778767C (enExample)
CA (1) CA2373603A1 (enExample)
HK (1) HK1046642B (enExample)
MX (1) MXPA01011760A (enExample)
WO (1) WO2000069430A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008506722A (ja) * 2004-07-21 2008-03-06 中国人民解放▲軍▼▲軍▼事医学科学院放射医学研究所 シス−１，２−置換スチルベン誘導体、および糖尿病の治療および／または予防のための薬剤の製造におけるそれらの使用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323496B2 (en) 1999-11-08 2008-01-29 Theracos, Inc. Compounds for treatment of inflammation, diabetes and related disorders
MXPA02007514A (es) * 2000-02-04 2004-02-26 Calyx Therapeutics Inc Compuestos novedosos de difeniletileno.
US6552085B2 (en) 2000-08-16 2003-04-22 Insmed Incorporated Compositions containing hypoglycemically active stilbenoids
US6410596B1 (en) * 2000-08-16 2002-06-25 Insmed Incorporated Compositions containing hypoglycemically active stillbenoids
CN1398838A (zh) 2001-07-26 2003-02-26 中国人民解放军军事医学科学院放射医学研究所 二苯乙烯类化合物制备以及它们在治疗和预防糖尿病中的应用
JP4781580B2 (ja) * 2001-09-26 2011-09-28 日本メナード化粧品株式会社 コラゲナーゼ阻害剤
US20050096256A1 (en) 2003-07-01 2005-05-05 President And Fellows Of Harvard College Compositions for manipulating the lifespan and stress response of cells and organisms
EP1708689A2 (en) 2003-12-29 2006-10-11 The President and Fellows of Harvard College Compositions for treating or preventing obesity and insulin resistance disorders
US8017634B2 (en) 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
WO2006138418A2 (en) 2005-06-14 2006-12-28 President And Fellows Of Harvard College Improvement of cognitive performance with sirtuin activators
CN100384801C (zh) * 2006-06-23 2008-04-30 中国科学院广州化学研究所 (e)-3,5-二甲氧基-4＇-羟基二苯乙烯的合成方法
FR2904311B1 (fr) 2006-07-28 2013-01-11 Clariant Specialty Fine Chem F Nouveau procede de synthese de derives (e) stilbeniques perm permettant d'obtenir le resveratrol et le piceatannol
FR2921921B1 (fr) 2007-10-03 2011-08-19 Clariant Specialty Fine Chem F Procede de synthese de composes polyhydroxystilbeniques.
CN107324976B (zh) * 2017-07-28 2020-06-16 安徽理工大学 一种制备(E)-β-烷基苯乙烯类化合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5314693A (en) * 1992-02-07 1994-05-24 Kioritz Corporation Pest control chemicals against pine wood nematodes
US5430062A (en) * 1992-05-21 1995-07-04 Research Corporation Technologies, Inc. Stilbene derivatives as anticancer agents
US5770620A (en) * 1995-06-19 1998-06-23 Ontogen Corporation Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
US5827898A (en) * 1996-10-07 1998-10-27 Shaman Pharmaceuticals, Inc. Use of bisphenolic compounds to treat type II diabetes
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008506722A (ja) * 2004-07-21 2008-03-06 中国人民解放▲軍▼▲軍▼事医学科学院放射医学研究所 シス−１，２−置換スチルベン誘導体、および糖尿病の治療および／または予防のための薬剤の製造におけるそれらの使用

Also Published As

Publication number Publication date
HK1046642B (zh) 2005-11-25
MXPA01011760A (es) 2003-09-04
EP1178788A4 (en) 2005-08-10
KR100598638B1 (ko) 2006-07-07
EP1178788A1 (en) 2002-02-13
KR20020012220A (ko) 2002-02-15
HK1046642A1 (en) 2003-01-24
AU778767C (en) 2006-09-07
WO2000069430A1 (en) 2000-11-23
AU778767B2 (en) 2004-12-23
CN1354659A (zh) 2002-06-19
CA2373603A1 (en) 2000-11-23
AU4085799A (en) 2000-12-05
CN1194674C (zh) 2005-03-30

Similar Documents

Publication Publication Date Title
US6245814B1 (en) Diphenylethylene compounds
TWI585093B (zh) 供治療代謝症候群或發炎性疾病的吡喃苯并吡喃基苯酚衍生物及醫藥組成物
AU2004229418B2 (en) Compounds for the treatment of metabolic disorders
US6624197B1 (en) Diphenylethylene compounds
KR101380140B1 (ko) 트리아세틸-3-히드록실페닐아데노신 및 혈지조절에 대한 용도
KR101192272B1 (ko) 대사 질환의 치료용 화합물
JP5451403B2 (ja) アドレノメデュリン産生増強剤
AU778767C (en) Novel diphenylethylene compounds
JP2001501950A (ja) ▲ｉｉ▼型糖尿病を治療するためのビスフェノール化合物の使用
US6448450B1 (en) 1-(3,5-dimethoxyphenyl)-2-(4-hydroxyphenyl)-ethylene for diabetes treatment
CN109476676B (zh) 旋光性吡喃并色烯基苯酚衍生物及包含其的药物组合物
KR101391905B1 (ko) 물질대사 장애의 치료용 화합물
US20070142427A1 (en) Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity
JP2521739B2 (ja) 肝臓疾患治療剤
JP2007197427A (ja) アディポネクチン産生強化剤
CN108403980B (zh) 一种降血糖植物提取物有效部位及其制备方法和应用
JP2006273839A (ja) アディポネクチン産生増進剤
JP2003521500A (ja) 新規ジフェニルエチレン化合物
NZ511065A (en) Diphenylethylene (stillbenzenes) compounds for treating diabetes
CN113121331B (zh) 具有环丙基的苯氧芳酸类化合物及其药学上可接受的盐，以及它们的制备方法和应用
LU84245A1 (fr) Esters de 2-thenoylmercaptopropionylglycine avec des hydroxybenzenes substitutes, leur procede de preparation et compositions pharmaceutiques en contenant
JP2013241473A (ja) アドレノメデュリン産生増強剤
JPH0228575B2 (ja) Kokanenzai
EP0518769A1 (fr) Nouveaux dérivés de benzoate d'éthanolamine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
JPS62103016A (ja) 抗潰瘍剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060512

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090414

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090710

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091208